Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United States.
Saved in:
| Title: | Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United States. |
|---|---|
| Authors: | Herrera-Restrepo O; GSK, Philadelphia, PA, USA., Jutlla G; GSK, London, UK., Graham J; RTI Health Solutions, Research Triangle Park, NC, USA., Carrico J; GSK, Philadelphia, PA, USA. justin.d.carrico@gsk.com., Grace M; RTI Health Solutions, Research Triangle Park, NC, USA., Kocaata Z; GSK, Wavre, Belgium., Clements DE; GSK, Philadelphia, PA, USA., Burman C; GSK, Philadelphia, PA, USA., Andani A; GSK, Wavre, Belgium., Shah H; GSK, London, UK. |
| Source: | PharmacoEconomics [Pharmacoeconomics] 2026 Jun; Vol. 44 (6), pp. 741-759. Date of Electronic Publication: 2026 Mar 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1179-2027 |
|---|---|
| DOI: | 10.1007/s40273-026-01599-z |
